CYTO Consulting is specialized in helping startup companies realize their first big commercial success.We conduct market research, as well as develop strategic business plans and tactical plans. www.cytoconsulting.com

Guangdong Ardent Biomed Co., Ltd (“ABIOM” in short) is a medical technology company, founded as a product development and research lab in Silicon Valley California in 2011, and established its product manufacturing and marketing center in Guangzhou High-Tech Industrial Development Zone in 2016.ABIOM is a one-stop R&D-production-service high-tech enterprise. The company product portfolio includes cloned and purified molecular diagnostic enzymes, reagent kits, diagnostic consumables, and molecular diagnostic instruments as well as providing molecular diagnostic services.https://www.ardentbiomedllc.com/

• Strategic and tactical business and marketing planning• Built strategic commercial relationships in the Pharma, Biotech, Dx and CRO space• Negotiated supply and licensing agreements and partnerships

• Responsible for 12% growth in the clinical and forensics market segments significantly above market growth and above AB SCIEX average• Launched 3 CE marked kits in Europe and medical devices in the US, Europe and China• Successfully initiated a turnaround of weaker businesses in the Asia Pacific region• Developed the first AB SCIEX business plan and strategy for forensics• Developed a balanced long and short term strategic plan including organic growth, partnerships, and acquisitions• Developed concept for breakthrough innovation platform in the clinical space

• Orchestrated double-digit sales growth for bulk and custom antibodies (0% growth in 2010 to 17% growth in 2013)• Created strategies to capture majority market share for blood typing antibodies (over 60% share)• Defined global product portfolio and marketing strategy for Merck/Millipore’s OEM diagnostic products• Built a high-functioning marketing team around core product areas such as mono- and polyclonal antibodies, membranes, chromatography media, and contract manufacturing• Successfully managed and influenced a matrix of product managers, marcom specialist, and technical marketing experts in the business-to-business market place• Created a marketing organization from the ground up establishing marketing plans, marketing collateral, tactical plans and effective marketing processes such as pricing tools, campaign tracking and multi-step marketing campaigns• Led a team of directors in a global marketing council with the goal of improving marketing effectiveness throughout the Merck/Millipore organization• Served as marketing lead in several global innovation projects in the areas of In Vitro Diagnostics (IVD) and companion diagnostic products

• Orchestrated Agilent’s first development and submission of an IVD device to the FDA (510(k) Notification - 2500 HDL Profile System, submitted September, 2009)• Marketing director for products in cardiovascular and infectious disease as well as in cancer and genetic testing• Charged with for generating $100M within the first 3 years of launching the first product• Built and perpetuated profitable business relationship with key customers• Design and implementation of global marketing strategies, programs and tactics for molecular diagnostics, including creating strategic partnerships and alliances• Led R&D team in developing Agilent’s first FDA approved IVD test in the area of novel markers for cardiovascular risk assessment• Coordinated all aspects of operational issues for diagnostics• Managed all stages of clinical assay development lifecycle: proposal, investigation, development, validation/design transfer, regulatory clearance• Initiated and supervised clinical utility study for HDL subfraction measurements.• Managed IP portfolio